new HIV med called Kaletra

October 2000

Abbott is now marketing a new HIV med called Kaletra.It contains TWO protease inhibitors...lopinavir plus a low dose of ritonavir (Norvir).

Lopinavir is the active antiretroviral in Kaletra.

Ritonavir is only a "booster." It inhibits lopinavir metabolism...resulting in higher and more sustained drug levels.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote